- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Transgene (0OCQ)
Transgene stock price live, this page displays EPA TRNG stock exchange data. View the TRNG premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Transgene real time stock price chart below.
What Is the Transgene Stock Price Today?
The Transgene stock price today is 1.050.
What Is the Stock Symbol for Transgene?
The stock symbol for Transgene is ""TRNG.""
What Stock Exchange Does Transgene Trade On?
Transgene is listed and trades on the Paris stock exchange.
Is Transgene a Good Stock to Buy?
Determining whether Transgene—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the TRNG quote. (ISIN: FR0005175080)
What Is the Transgene Stock Price Today?
The Transgene stock price today is 1.050.
What Is the Stock Symbol for Transgene?
The stock symbol for Transgene is ""TRNG.""
What Stock Exchange Does Transgene Trade On?
Transgene is listed and trades on the Paris stock exchange.
Is Transgene a Good Stock to Buy?
Determining whether Transgene—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the TRNG quote. (ISIN: FR0005175080)
1.050
+0.020(+1.94%)
Closed·
Fair Value
An estimate of a Transgene's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.020
1.050
52 wk Range
0.560
1.174
0OCQ Scorecard
Full Analysis
Quickly burning through cash
0OCQ is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Transgene's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.0201.050
52 wk Range
0.5601.174
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
0OCQ Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Transgene's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Neutral
Transgene Company Profile
Transgene SA, a biotechnology company, designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer in France. It involved in developing TG4050, a therapeutic vaccine that is in Phase II clinical trial for the treatment of ovarian cancer, and head and neck cancers; TG4001, a therapeutic vaccine, which is in Phase II clinical trial for the treatment of human papillomavirus (HPV 16) positive cancers; TG6002, an oncolytic virus that is in Phase I/IIa clinical trial for the treatment of solid tumors, including gastrointestinal adenocarcinoma; and BT-001, an oncolytic virus, which is in Phase I/II clinical trial for the treatment of solid tumors. The company also develops TG6050 for the treatment of non-small cell lung cancer that is in Phase 1 clinical trial; and Pexa-Vec, an oncolytic virus for the treatment of solid tumors. It has strategic collaboration agreements with AstraZeneca, Merck KGaA, Pfizer, and NEC Corporation; licensing agreements with SillaJen, Ascend BioPharmaceutical, and Valneva; and agreements with Merck & Co, Sanofi, and BioInvent. The company was incorporated in 1979 and is headquartered in Illkirch-Graffenstaden, France. Transgene SA is a subsidiary of TSGH SAS.
Compare 0OCQ to Peers and Sector
Metrics to compare | 0OCQ | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship0OCQPeersSector | |
|---|---|---|---|---|
P/E Ratio | −4.0x | −3.0x | −0.5x | |
PEG Ratio | 0.13 | 0.03 | 0.00 | |
Price/Book | 9.0x | 1.4x | 2.6x | |
Price / LTM Sales | 21.5x | 4.5x | 3.3x | |
Upside (Analyst Target) | - | 185.5% | 43.5% | |
Fair Value Upside | Unlock | 14.0% | 6.9% | Unlock |
Earnings
Latest Release
Apr 24, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Stock Exchange Does Transgene Trade On?
Transgene is listed and trades on the London Stock Exchange stock exchange.
What Is the Stock Symbol for Transgene?
The stock symbol for Transgene is "0OCQ."
What Is the Transgene Market Cap?
As of today, Transgene market cap is 136.35M.
What Is Transgene's Earnings Per Share (TTM)?
The Transgene EPS (TTM) is -0.29.
When Is the Next Transgene Earnings Date?
Transgene will release its next earnings report on 03 Nov 2025.
From a Technical Analysis Perspective, Is 0OCQ a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Transgene Stock Split?
Transgene has split 0 times.
How Many Employees Does Transgene Have?
Transgene has 144 employees.
What is the current trading status of Transgene (0OCQ)?
As of 07 Aug 2025, Transgene (0OCQ) is trading at a price of 1.05, with a previous close of 2.03. The stock has fluctuated within a day range of 1.02 to 1.05, while its 52-week range spans from 0.56 to 1.17.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.